ATE169014T1 - Kaliumsalz eines biphenylmethanderivates und dasselbe enthaltendes medikament - Google Patents

Kaliumsalz eines biphenylmethanderivates und dasselbe enthaltendes medikament

Info

Publication number
ATE169014T1
ATE169014T1 AT95907860T AT95907860T ATE169014T1 AT E169014 T1 ATE169014 T1 AT E169014T1 AT 95907860 T AT95907860 T AT 95907860T AT 95907860 T AT95907860 T AT 95907860T AT E169014 T1 ATE169014 T1 AT E169014T1
Authority
AT
Austria
Prior art keywords
compound
same
potassium salt
medication containing
mono
Prior art date
Application number
AT95907860T
Other languages
English (en)
Inventor
Terukage Hirata
Nobuya Sakae
Koichi Tamura
Masayasu Okuhira
Hirotaka Amano
Masaharu Yokomoto
Jun Nomiyama
Original Assignee
Wakunaga Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakunaga Seiyaku Kk filed Critical Wakunaga Seiyaku Kk
Application granted granted Critical
Publication of ATE169014T1 publication Critical patent/ATE169014T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/48—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT95907860T 1994-02-10 1995-02-08 Kaliumsalz eines biphenylmethanderivates und dasselbe enthaltendes medikament ATE169014T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1622094 1994-02-10
JP12873994 1994-06-10

Publications (1)

Publication Number Publication Date
ATE169014T1 true ATE169014T1 (de) 1998-08-15

Family

ID=26352497

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95907860T ATE169014T1 (de) 1994-02-10 1995-02-08 Kaliumsalz eines biphenylmethanderivates und dasselbe enthaltendes medikament

Country Status (10)

Country Link
EP (1) EP0744402B1 (de)
KR (1) KR970700672A (de)
CN (1) CN1140450A (de)
AT (1) ATE169014T1 (de)
CA (1) CA2181260A1 (de)
DE (1) DE69503760T2 (de)
DK (1) DK0744402T3 (de)
ES (1) ES2120180T3 (de)
GR (1) GR3027777T3 (de)
WO (1) WO1995021837A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996009301A1 (fr) * 1994-09-20 1996-03-28 Wakunaga Seiyaku Kabushiki Kaisha Procede de production d'un derive de n-biphenylmethylthiadiazoline ou un sel de celui-ci et son intermediaire de production
WO1997001557A1 (fr) * 1995-06-27 1997-01-16 Wakunaga Seiyaku Kabushiki Kaisha Procede de production de derives de biphenylmethane tetrazolyles

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5326776A (en) * 1992-03-02 1994-07-05 Abbott Laboratories Angiotensin II receptor antagonists
CA2141792A1 (en) * 1992-08-11 1994-02-12 Terukage Hirata Biphenylmethane derivatives and pharmaceuticals containing the same
WO1996009301A1 (fr) * 1994-09-20 1996-03-28 Wakunaga Seiyaku Kabushiki Kaisha Procede de production d'un derive de n-biphenylmethylthiadiazoline ou un sel de celui-ci et son intermediaire de production

Also Published As

Publication number Publication date
DE69503760D1 (de) 1998-09-03
KR970700672A (ko) 1997-02-12
AU685586B2 (en) 1998-01-22
EP0744402A4 (de) 1997-03-26
WO1995021837A1 (fr) 1995-08-17
EP0744402B1 (de) 1998-07-29
GR3027777T3 (en) 1998-11-30
EP0744402A1 (de) 1996-11-27
ES2120180T3 (es) 1998-10-16
CA2181260A1 (en) 1995-08-17
DE69503760T2 (de) 1998-12-17
CN1140450A (zh) 1997-01-15
AU1591295A (en) 1995-08-29
DK0744402T3 (da) 1999-05-03

Similar Documents

Publication Publication Date Title
DE122006000051I1 (de) Ester der 5-Aminolevulins{ure als Mittel zur Photosensibillisierung in der Chemotherapie
TNSN04246A1 (fr) Derives d'heteroarylamides benzocondenses de thienopyridines utiles comme agents therapeutiques, compositions pharmaceutiques les contenant et methodes pour leur utilisation
TNSN05165A1 (fr) Derives de pyrrolopyrimidine
MA28011A1 (fr) Derives de piperazine et leur utilisation en tant qu'agents therapeutiques
ATE164080T1 (de) Pharmazeutische zubereitung enthaltend n- glykofurole und n-äthylenglykole
GEP20002298B (en) Benzimidazole Derivatives, Method of Their Production, Pharmaceutical Composition Containing the Same and Method for Its Treatment
LV12291A (lv) Savienojums un farmaceitiskas kompozicijas ar triptazes aktivitates izmainam saistitu slimibu arstesanai
BRPI0409427A (pt) composto, uso do mesmo, composição farmacêutica, método de tratamento de um humano sofrendo de uma doença hiperproliferativa, e, processo para a preparação de um composto ou de um sal, éster ou pró-droga farmaceuticamente aceitáveis do mesmo
DE69429328D1 (de) N-(3-piperidinylcarbonyl)-b-alanin derivate als paf-antagonisten
RU2002100058A (ru) Кристаллические производные 1-метилкарбапенема
ATE101138T1 (de) Parabansaeure-derivate und pharmazeutische zusammensetzungen damit.
ATE169014T1 (de) Kaliumsalz eines biphenylmethanderivates und dasselbe enthaltendes medikament
DE69217613D1 (de) Stickstoff enthaltende bizyklische Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE10299023I2 (de) Antineoplastisch wirkender und den antineoplastischen effekt verstärkender wirkstoff
KR950702544A (ko) 비페닐메탄 유도체 및 이를 함유하는 약제
ATE331523T1 (de) Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion
FI964303A (fi) Keuhkosydänvian hoitamiseen tarkoitettu aine
FI923662A (fi) Terapeutiska medel
EP2266566A3 (de) Nicotinamid Derivate und ihrer Verwendung als Therapeutika
DE69328585D1 (de) Neue Alkaloidderivate, ihre Verwendung und diese enthaltende pharmazeutische Formulierungen
DK1142575T3 (da) Lægemidler til tör hud
FR2845087B1 (fr) Nouveaux acides arylhexadienoiques substitues et leurs esters,utilisables dans le traitement et la prevention du diabete, des dyslipidemies,de l'atherosclerose, compositions pharmaceutiques les contenant et procedes de preparation
NO961180L (no) Transdermal anordning inneholdende (E)-2-(p-fluorfenetyl)-3-fluorallylamin for behandling av Alzheimers sykdom
GEP20043356B (en) Compounds Useful For Treatment or Prevention of Diseases Mediated By Alpha- 2B-Adrenoceptor
TH16370A (th) สารประกอบไดแอริล

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee